Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: Randomised controlled non-inferiority trial
Overview
This randomized controlled trial compares the efficacy of mindfulness-based cognitive therapy (MBCT) combined with antidepressant discontinuation versus continued medication for preventing depressive relapse in adults with recurrent depression. The study found that stopping medication was associated with a higher risk and faster time to relapse compared to continuing it, indicating that discontinuation may not be non-inferior. This resource is relevant for clinicians and researchers examining treatment protocols for maintenance therapy in recurrent depression.
- ID
9b64aac93f974b80- Source org
- OpenAlex
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.1192/bjp.bp.115.168971
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:9b64aac93f974b80,
title = {Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: Randomised controlled non-inferiority trial},
journal = {OpenAlex},
doi = {10.1192/bjp.bp.115.168971},
url = {https://doi.org/10.1192/bjp.bp.115.168971}
}RIS
TY - JOUR TI - Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: Randomised controlled non-inferiority trial PB - OpenAlex DO - 10.1192/bjp.bp.115.168971 UR - https://doi.org/10.1192/bjp.bp.115.168971 ER -
APA
Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: Randomised controlled non-inferiority trial. (n.d.). OpenAlex. https://doi.org/10.1192/bjp.bp.115.168971
Related entries
- Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study
- The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study)
- Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial
- The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication
- Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
- Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial
- The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial
- Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse
- Treatment-resistant depressed patients show a good response to Mindfulness-based Cognitive Therapy
- Mindfulness-Based Cognitive Therapy: Theory and Practice